Epigenetic Consortium
The Global Epigenetic Age Consortium is dedicated to summarizing current evidence, interpreting clinical relevance and associations, and advancing the clinical translation of epigenetic clocks as tools for precision medicine research and practice.
Objective
- We are leading a series of systematic reviews and meta-analyses to rigorously evaluate the performance, validity, and applicability of epigenetic clocks in relation to mortality risk, age-related diseases, and risk factors across diverse populations.
- Our goal is to bridge the gap between research and clinical application by identifying clocks that are most suitable and validated for health outcomes, such as age-related diseases and mortality, thereby informing guidelines for their adoption in clinical trials and translation into healthcare settings.
- By leveraging the collective expertise and resources of global networks, including the Healthy Longevity Medicine Society and the Biomarkers of Aging Consortium, we accelerate evaluation efforts and provide robust, collective evidence supporting the use of epigenetic clocks.
Project Overview
Facilitate the translation of biological clocks into clinical practice
Founder: Prof Andrea Maier
Project manager: Dr Wang Weilan and Mr Tay Jian Hua
Team Members
•Adriana Bota, NA
•Arian Daneshpour, USERN, Iran
•Atikah Dahiyah, National University of Singapore (NUS)
•Austeja Bakulaite, University of Portsmouth
•Audrey Low, Mayo Clinic Rochester (USA)
•Bhirau Wilaksono, NA
•Cheng Soh, Baker Heart and Diabetes Institute
•Chong Hui Min, National University of Singapore (NUS)
•Duarte Barros, University of Porto
•Georgia Isabella Bailey, University of Vienna
•Guili Zhao, NA
•He Qian, National University of Singapore
•Hiba Hamid, NA
•Jiajun Dong, National University of Singapore
•Kavya Gupta, NA
•Lim Zhi Meng, National University of Singapore
•Liu Cong, National University of Singapore (NUS)
•Luisa Georgiana Baca, NIH/NIA, BoA
•Mariela Marazita, Neuroscience Institute, INEU-FLENI-CONICET
•Maryam Saad, Ministry of Health and Population, Egypt
•Matthew Simonson, University of Illinois at Chicago
•Meilan Feng, NA
•Merve Eskici Göç, Istanbul University Cerrahpasa
•Muqadas Bhatti, Bahria University
•Prof. Brendon Stubbs, King’s College London
•Prof. Shaun Sabico, King Saud University
•Purnima BR, NA
•Raaj Biswas, The University of Sydney
•Raissa, Lawrence, NA
•Riise Tan, Temasek Polytechnic
•Rizana Riyaz, The University of Sheffield
•Sabarinath Nair, National University of Singapore
•Sayan Mitra, The University of Sydney
•Sehar Tejani, Alfaisal University
•Sharon Nadiyah, National University of Singapore (NUS)
•Shan Jiatong, National University of Singapore
•Stacia P. A. Everts, University of Amsterdam
•Suvathi, SingHealth Polyclinics, Singapore
•Tay Jian Hua, National University of Singapore
•Teresa Reindl, Karolinska Institutet
•Vo Hue Man, ASEAN Center for Active Ageing and Innovation
•Yin Nyein, Chulalongkorn University
•Wang Jiaqiu, Zhejiang University
•Yu Luo, NA
•Zahra Oskouei, Mashhad University of Medical Sciences, Iran
•Zaylea Kua, National University of Singapore
•Zhang Qing, Fudan University
•Jiaxin Zhao, NA
Research Highlights/Publication
- Two manuscripts submitted to Lancet Healthy Longevity (reviewing stage)
- Six meta-analyses done
- Calling for more volunteers